Advanced search
Publication Cover
Nordic Journal of Psychiatry Volume 77, 2023 - Issue 2
Submit an article Journal homepage
1,267
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Resource utilization in mental illness – evaluation of an instrument for measuring direct costs of treatment for patients with severe mental illness (SMI)

Richard Stenmarka Department of Clinical Sciences Lund, Severe Mental Illness Research Unit, Lund University, Psychiatry Research Center, Region Skåne, Lund, SwedenCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1828-7770View further author information
ORCID Icon,
Jonas Eberharda Department of Clinical Sciences Lund, Severe Mental Illness Research Unit, Lund University, Psychiatry Research Center, Region Skåne, Lund, Sweden;b Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UKORCID Iconhttps://orcid.org/0000-0003-0364-2626View further author information
ORCID Icon,
Gunnar Edmanc Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden;d Research and Development, Norrtälje Hospital, Tiohundra AB, Norrtälje, SwedenView further author information
,
Fiona Gaughrane South London and Maudsley NHS Foundation Trust, London, UK;b Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UKORCID Iconhttps://orcid.org/0000-0001-7414-5569View further author information
ORCID Icon &
Erik Jedeniusa Department of Clinical Sciences Lund, Severe Mental Illness Research Unit, Lund University, Psychiatry Research Center, Region Skåne, Lund, SwedenView further author information
Pages 172-178 | Received 06 Apr 2021, Accepted 09 May 2022, Published online: 01 Jun 2022

References

  • Charrier N, Chevreul K, Durand-Zaleski I. The cost of schizophrenia: a literature review. Encephale. 2013;39(Suppl. 1):S49–S56.
  • World Health Organization. The World Health Report: report of the Director-General. 2001, mental health: new understanding, new hope. Geneva: World Health Organization; 2001.
  • Jin H, Mosweu I. The societal cost of schizophrenia: a systematic review. Pharmacoeconomics. 2017;35(1):25–42.
  • Ekman M, Granstrom O, Omérov S, et al. Costs of bipolar disorder, depression, schizophrenia and anxiety. The right treatments can have significant positive socio-economic effects. Läkartidningen. 2014;111(34–35):1362–1364.
  • Fasseeh A, Németh B, Molnár A, et al. A systematic review of the indirect costs of schizophrenia in Europe. Eur J Public Health. 2018;28(6):1043–1049.
  • Chi MH, Hsiao CY, Chen KC, et al. The readmission rate and medical cost of patients with schizophrenia after first hospitalization – a 10-year follow-up population-based study. Schizophr Res. 2016;170(1):184–190.
  • Liffick E, Mehdiyoun NF, Vohs JL, et al. Utilization and cost of health care services during the first episode of psychosis. Psychiatr Serv. 2017;68(2):131–136.
  • Murphy SM, Kucukgoncu S, Bao Y, et al. An economic evaluation of coordinated specialty care (CSC) services for first-episode psychosis in the U.S. public sector. J Ment Health Policy Econ. 2018;21(3):123–130.
  • Taipale H, Mittendorfer-Rutz E, Alexanderson K, et al. Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia. Schizophr Res. 2018;197:274–280.
  • Tiihonen J, Mittendorfer-Rutz E, Majak M, et al. P.3.d.014 – real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29,823 patients. Eur Neuropsychopharmacol. 2017;27:S937.
  • Wimo A, Jonsson L, Zbrozek A. The Resource Utilization in Dementia (RUD) instrument is valid for assessing informal care time in community-living patients with dementia. J Nutr Health Aging. 2010;14(8):685–690.
  • Beecham J, Knapp M. Costing psychiatric interventions. In: Thornicroft G, editor. Measuring mental health needs. 2nd ed. London: Gaskell; 2001.
  • Wimo A, Wetterholm AL, Mastey V, et al. Evaluation of the resource utilization and caregiver time in anti-dementia drug trials – a quantitative battery. In: Vimo A, Jönsson B, Karlsson G, Winblad B, editors. The health economics of dementia; 1998. p. 465–499. Chichester; New York: Wiley.
  • Chisholm D, Knapp MRJ, Knudsen HC, et al. Client socio-demographic and service receipt inventory – European version: development of an instrument for international research: EPSILON study 5. Br J Psychiatry. 2000;177(S39):s28–s33.
  • Westman J, Eberhard J, Gaughran FP, et al. Outcome of a psychosocial health promotion intervention aimed at improving physical health and reducing alcohol use in patients with schizophrenia and psychotic disorders (MINT). Schizophr Res. 2019;208:138–144.
  • Wimo A, Gustavsson A, Jönsson L, et al. Application of Resource Utilization in Dementia (RUD) instrument in a global setting. Alzheimer's Dement. 2013;9(4):429–435.e417.
  • Endicott J, Spitzer RL, Fleiss JL, et al. The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33(6):766–771.
  • Guy W. Universal scales, Clinical Global Impressions (028-CGl), 217. In: Rush JA, editor. ECDEU assessment manual for psychopharmacology; 1976. Rockville, Maryland: U.S. Department of Health, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute of Mental Health Psychopharmacology Research Branch Division of Extramural Research Programs.
  • Tigbe WW, Briggs AH, Lean MEJ. A patient-centred approach to estimate total annual healthcare cost by body mass index in the UK counterweight programme. Int J Obes. 2013;37(8):1135–1139.
  • Wang WF, McDonald WT, Bender WJ, et al. Association of healthcare costs with per unit body mass index increase. J Occup Environ Med. 2006;48(7):668–674.
  • Ekman M, Granstrom O, Omerov S, et al. The societal cost of schizophrenia in Sweden. J Ment Health Policy Econ. 2013;16(1):13–25.
  • Lindström E, Eberhard J, Neovius M, et al. Costs of schizophrenia during 5 years. Acta Psychiatr Scand. 2007;116(S435):33–40.
  • Lally J, Watkins R, Nash S, et al. The representativeness of participants with severe mental illness in a psychosocial clinical trial. Front Psychiatry. 2018;9:654.
  • McDaid D, Park A-L. 2020. Understanding the value and impacts of informal care for people living with poor mental health (caring report corrected version 2). Available from: http://eufami.org/wp-content/uploads/2017/03/caring-report-_corrected-version-2_.pdf

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.